-
AbbVie Inc. (ABBV $208.36)
-
Cybin Inc Com (CX $0.14)
-
COMPASS Pathways Plc (CMPS $4.76)
-
Mind Medicine (MindMed) Inc. (MNMD $9.99)
Q: What is your opinion of ABBV buying an experimental drug derived in the psychedelic space from private company Gilgamesh for 1.2B?. Do you think with some of these psychedelic companies now getting phase 2 and phase 3 trials wrapped up on their potential drug offerings that the psychedelic market might get some legs in the near future as the big pharma companies look for the next big thing. ? With these being very spec who would be you picks in the space for fun money?